Page 83 - MemoriaOBN-Eng

www.ciberobn.es

• l e, t Mi, a J, a F, F-F Ja, r J. Prevalence
Most relevant urBeorrolVarezGuilarernánDezorMosoeDon
and factors related to urinary albumin excretion in obese youths.J Hypertens. 2013
scientific Nov;31(11):2230-6; discussion 2236.

articles
• o’Brien e, Parati G, sterGiou G, asMar r, Beilin l, Bilo G et al.. European society of
hypertension position paper on ambulatory blood pressure monitoring.J Hypertens.

2013 Sep;31(9):1731-68.

• lurBe e. Childhood blood pressure: trends and future tracks.Hypertension. 2013
Aug;62(2):242-3.

• l e, t l, t Mi, a J, s Ja, r J. Sexual dimorphism in the
urBehiJsorrolVareztaesseneDon
transition from masked to sustained hypertension in healthy youths.Hypertension.
2013 Aug;62(2):410-4.

• M-G F, M Ml, r-M G, D M-s G, M s, s
artínezarcíaanseGooJoartínezearcoolarorcillooriGuer
F et al.. Impact of obesity-related genes in Spanish population.BMC Genet. 2013
Nov 23;14:111.

CHILDHOOD OBESITY AND APPLICATIONS OF NEW TECHNOLOGIES.
Highlights
• The PAIDO programme, which uses a holistic approach in the management of

childhood obesity. The program has received the National award from NAOS.

• The PEDITEC Programme, an “unit of action” created with the Polytechnical
University of Valencia (VLCCAmpus). The programme utilizes medical personnel

dedicated to the management of obesity with engineers that develop software

to capture signals (cardiorespiratory fitness, adrenergic energy, response to
exercise), through mobile devices, intelligent t-shirts, for the study of physiological

parameters that allow for individualized treatment.

PHYSICAL ACTIVITY IN THE PREVENTION AND TREATMENT OF OBESITY.
•
Personalised home-based physical activity programmes through the use of mobile
devices, eTIOBE.

STUDY OF THE IMPACT OF INTRAUTERINE LIFE AND POSTNATAL GROWTH IN THE

DEVELOPMENT OF CARDIOVASCULAR DISEASE
•
Prospective study from birth (FIS project, EUROPA project) which have arrived to
10 years of life in more than 100 subjects. Data on umbilical cord and follow-up

of clinical parameters and cardiometabolic phenotype.

HYPERTENSION IN OBESITY
•
Studies focused on the components of functional and organic alteration in the
large vessels of obese patients with high-normal blood pressure and hypertension.

CARDIOVASCULAR AND RENAL RISK IN OBESITY

• Development of the ESH European Guidelines for the diagnosis, evaluation and

treatment of hypertension, as well as the Guidelines for ambulatory blood pressure 13
monitoring (ESH).
0
2
• European project for the study of biomarkers of cardiovascular risk through the RT
PO
use of –omics (EU-MASCARA).
E
R
• Studies of early renal damage in obesity through the evaluation of podocytes, its AL
U
molecular phenotype and transcriptomes.
NN
A
• Studies on the genomic-metabolomic interaction to identify genetic markers /
associated with the development of early renal damage related to obesity.
BN
O
ER
B
CI

83